Association Between Fibromyalgia and Risk of Developing Sarcopenia According SARC-F: A Cross-Sectional Study
Authors:
- Blanca Pedauyé-RuedaBPBlanca Pedauyé-Rueda
- Eduardo Cimadevilla Fernández-PolaEFEduardo Cimadevilla Fernández-Pola
- Hilin HusseinHHHilin Hussein
- Cristina Ojedo-MartínCOCristina Ojedo-Martín
- María Jesús Fernández-AceñeroMFMaría Jesús Fernández-Aceñero
- Juan Hernández-LougedoJHJuan Hernández-Lougedo
- Noemí Mayoral-GonzaloNMNoemí Mayoral-Gonzalo
- Juan Pablo Hervás-PérezJuan Pablo Hervás-Pérez
- Edurne Úbeda-D’ocasarEÚEdurne Úbeda-D’ocasar
Open Access
- 24 December 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (1) , 62
Abstract
Background: Fibromyalgia (FM) is a condition characterised by chronic pain, which may or may not be associated with muscular stiffness. Sarcopenia is the progressive loss of muscle mass and strength. The loss of muscle mass is a key factor in the progression of both fibromyalgia and sarcopenia and therefore warrants thorough evaluation. It has been demonstrated that obesity directly influences factors that increase pain perception and disease severity and reduce quality of life. The primary objective of this study was to examine the association between fibromyalgia and the increased risk of developing sarcopenia. Methods: The sample consisted of 84 patients diagnosed with FM. We assessed sociodemographic characteristics, anthropometric variables (circumferential and ultrasound) pain with a Visual Analogue Scale (VAS) and algometry, risk of developing sarcopenia with SARC-F, quality of sleep, anxiety, and depression using validated questionnaires. Results: A total of 96.3% of the participants were women. Overall, 56.3% of the sample presented a high risk of sarcopenia according to SARC-F, VAS scores showed significant negative correlations with anxiety (p < 0.01) and with almost all algometric measures (p < 0.05). The Fibromyalgia Impact Questionnaire (FIQ) demonstrated a positive and significant correlation with sleep quality (p < 0.01) and depression (p < 0.01). Furthermore, presence of a high risk of sarcopenia according to SARC-F was significantly associated with FIQ scores (p = 0.002) and depression (p < 0.001). Conclusions: There is a significant association between the impact of FM and a high risk of developing sarcopenia according to SARC-F. This population exhibits a high degree of pain, which are significantly associated with elevated levels of anxiety and depression.Keywords
Funding Information
- Universidad Camilo José Cela (X Convocatoria de Investigación Interna)
This publication has 42 references indexed in Scilit:
- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and TreatmentJournal of the American Medical Directors Association, 2020
- Sarcopenia, frailty and their prevention by exerciseFree Radical Biology and Medicine, 2019
- Assessing sarcopenia with vastus lateralis muscle ultrasound: an operative protocolAging Clinical and Experimental Research, 2018
- Systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitationOsteoporosis International, 2018
- Sarcopenia is a risk factor for complications and an independent predictor of hospital length of stay in trauma patientsJournal of Surgical Research, 2018
- Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesisAgeing Research Reviews, 2017
- Ultrasound‐Based Detection of Low Muscle Mass for Diagnosis of Sarcopenia in Older AdultsPM&R, 2015
- SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomesJournal of Cachexia, Sarcopenia and Muscle, 2015
- Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adultsOsteoporosis International, 2013
- Neuroendocrine dysfunction in fibromyalgia and migraineCurrent Pain and Headache Reports, 2009